Citicoline (Cognizin) in the treatment of cognitive impairment. - Wikidata - wikimedia - TriplyDB

Citicoline (Cognizin) in the treatment of cognitive impairment.

Citicoline (Cognizin) in the treatment of cognitive impairment.

http://www.wikidata.org/entity/Q34719672

about

Interventions for preventing delirium in hospitalised non-ICU patients Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives Citicoline in addictive disorders: a review of the literature Effects of citicoline therapy on the network connectivity of the corpus callosum in patients with leukoaraiosis The effects of dietary choline.Influence of energy drink ingredients on mood and cognitive performance.Efficacy of cognitive intervention in stroke: A long road ahead.Pharmacotherapy for Vascular Cognitive Impairment.

P2860

Q24186034-959FEC0C-6CCC-44FD-9B2E-8D7FED942841 Q24602094-61680D58-44BD-47AE-A247-D0ECF39CDCBF Q26781186-7E919454-40F5-4372-A6C8-8B4FAD37AF8E Q27014895-A1B92E56-F480-4ACB-B234-D346CDDD8057 Q37619540-37DABE4B-3740-4B62-BBC6-3C4EA4BD8F15 Q37936218-93787F7D-22F4-483C-B302-41AE30ADBE9D Q38257905-54336D30-BA86-413D-93AE-B177532C913E Q38673767-8776E92B-23E2-49CE-AC22-446FB12DC13D Q54440823-EBA5E07B-E6AA-4465-97F6-C49CE8129F34

P2860

Citicoline (Cognizin) in the treatment of cognitive impairment.

http://www.wikidata.org/entity/Q34719672

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Citicoline (Cognizin) in the treatment of cognitive impairment.

@ast

Citicoline (Cognizin) in the treatment of cognitive impairment.

@en

type

label

Citicoline (Cognizin) in the treatment of cognitive impairment.

@ast

Citicoline (Cognizin) in the treatment of cognitive impairment.

@en

prefLabel

Citicoline (Cognizin) in the treatment of cognitive impairment.

@ast

Citicoline (Cognizin) in the treatment of cognitive impairment.

@en

P1433

Q34719672-A493BD04-73B9-4656-9ED6-CBF3B46E32FB

P1476

Q34719672-00B66EAB-7AB8-4566-BB20-409FD711F607

P2093

Q34719672-68EBEC26-BB09-496D-BDC1-1CE6D038FF8B

P2860

Q34719672-085E0DCB-AF7E-49D8-817A-481279FCA87A

Q34719672-0BB3E799-FDEC-492D-9CAB-E14242A6734D

Q34719672-211F2B83-4F75-40C6-8E47-5736B5A2924A

Q34719672-2621609D-EFAA-4430-92EB-19095BE54BEE

Q34719672-276E02D3-2DD0-4B60-8440-A0309D623CE9

Q34719672-2F595F8A-C07D-4D37-A4B6-FB425EF45DEA

Q34719672-3A7D4313-DC83-4252-AF9F-EDADEC81AF5B

Q34719672-3F237DCD-4242-4B21-9092-1C74BE9C9A6A

Q34719672-49372714-6303-487B-88E6-910A485410B3

Q34719672-4D887A89-AAD0-45BC-82E6-228D25176EEC

P304

Q34719672-55549B8E-0B07-4DD8-B8FC-505BDE6D3337

P31

Q34719672-DE25C50F-8CCD-433C-9553-F340E8F934B2

P356

Q34719672-6E43EECD-74E5-427A-985B-134EF2115964

P407

Q34719672-7F310E27-5C01-4BAA-A28A-5E7B88B9C633

P433

Q34719672-A62AC6D3-E59A-4B98-B9FC-8810A9E3F836

P478

Q34719672-8B2A25DA-93B3-4451-815E-597805AD0C6B

P50

Q34719672-406197E1-DCAE-4EE0-9077-70DDD39C3B3C

P577

Q34719672-96B27F74-AD07-4DDB-8CE8-EC9DF26B1246

P5875

Q34719672-78B16763-056D-4114-B0FB-E932929BAA91

P698

Q34719672-EB61A69D-4108-4764-8DE8-5B134BD2C51D

P921

Q34719672-7AD5894C-2475-43D7-82B8-0C6AB28C7C15

Q34719672-BA5D0200-FF17-4ACA-9F69-B70155457950

P932

Q34719672-570887F9-0EE3-4D2E-87BC-2647AB2F848C

P356

CIIA.2006.1.3.247

P1433

Clinical Interventions in Aging

P1476

Citicoline (Cognizin) in the treatment of cognitive impairment

@en

P2093

Ann E Buckley

http://www.w3.org/2001/XMLSchema#string

P2860

Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly

Glycerophosphocholine catabolism as a new route for choline formation for phosphatidylcholine synthesis by the Kennedy pathway.

"Brain-specific" nutrients: a memory cure?

Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.

Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data

Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.

CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.

Clinical use of cholinomimetic agents: a review.

Membrane stabilizer: citicoline.

Longitudinal volumetric MRI change and rate of cognitive decline.

P304

247-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CIIA.2006.1.3.247

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Mario Fioravanti

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5800806

http://www.w3.org/2001/XMLSchema#string

P698

18046877

http://www.w3.org/2001/XMLSchema#string

P921

cognitive disorder

CDP-choline (1+)

P932

2695184

http://www.w3.org/2001/XMLSchema#string